Véronique Gobry Caregiver

Veronique’s husband, Fred Gobry, was diagnosed with Multiple Myeloma in 2014. Since then, she has been committed to raising awareness and fundraising for the MMRF. In 2015 she joined the first hike fundraiser for the MMRF – Moving Mountains for Multiple Myeloma – in the Grand Canyon. She continued to support supporting the efforts of the MMRF the following years by completing several half-marathons with the Team for Cures. In 2019, new to cycling, she joined the R2V team, and now in 2022, she and is thrilled to embark in this new adventure this time together with her husband, Fred.


R2V gives me something I can do to help and support my husband…
Veronique Gobry
Only three short days before the start of the R2V Vermont to Quebec Ride, an event I am very grateful for having the opportunity to be part of.  My husband…
Read More
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More